Hybrid epicardial-endocardial ablation with LAA exclusion demonstrated a significant reduction in atrial arrhythmia recurrence** through 3 years of follow-up compared to endocardial ablation alone in patients with advanced forms of AF*.
At 3 years, data showed:
- 61.1% primary effectiveness of hybrid ablation vs 27.5% endocardial ablation only
- 122% relative benefit of hybrid over endocardial ablation only
Learn more about the CEASE-AF data: <a href="https://lnkd.in/ex5-hfFe" target="_blank">https://lnkd.in/ex5-hfFe</a>
*Persistent or long-standing persistent AF**Effectiveness was freedom from AF, atrial flutter, atrial tachycardia (> 30 sec); absent new/increased dose of previously failed class I/III anti-arrhythmic drugs
<a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=afib&highlightedUpdateU…; target='_blank'>#afib</a>
